Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 6;17(1):167.
doi: 10.1186/s12889-017-4083-4.

Active surveillance study of adverse events following immunisation of children in the Czech Republic

Jana Danova  1 , Aneta Kocourkova  2 , Alexander M Celko  2
Affiliations

Active surveillance study of adverse events following immunisation of children in the Czech Republic

Jana Danova et al. BMC Public Health. .

Abstract

Background: Despite the undisputed public health benefits of routine vaccination, adverse events following immunisation (AEFI) remain a concern. As most adverse events are mild, they may be under-reported; this may underlie the wide range of AEFI rates reported in the literature. We investigated the rates of AEFI related to routine vaccination of children 0-10 years old in the Czech Republic.

Methods: The study reviewed patients' records in a sample of 49 paediatric GP practices covering all 12 administrative regions of the Czech Republic between 2011 and 2013. Adverse events following routine immunisation of children aged 0-10 years were identified and recorded.

Results: The overall rate of AEFI was 209/100,000 doses; this was 6 times higher than the rate reported to the Czech State Institute for Drug Control (34/100,000 doses). Over two fifths (44%) of all AEFI occurred after the booster dose of the combined diphteria, tetanus and pertussis vaccine in 5-year old children. The vast majority of AEFI were non-serious local events (e.g. redness) and fever. Most AEFI occurred the second day after the immunisation, lasted 4 days on average, and were treated by cold therapy, antipyretics and analgesics.

Conclusions: The rate of AEFI identified in this study was considerably higher than the officially reported rate. Although the vast majority of AEFI were non-serious, health care providers and the public should be educated and encouraged to report AEFI to address the issue of underreporting, to increase the safety profile of vaccines, and to improve public confidence in immunisation programmes.

Keywords: Adverse events following immunisation; Children; Vaccination; Vaccine.

PubMed Disclaimer

References

    1. Cherian T, Okwo-Bele JM. The decade of vaccines global vaccine action plan: shaping immunization programmes in the current decade. Expert Rev Vaccines. 2014;13(5):573–575. doi: 10.1586/14760584.2014.897618. - DOI - PubMed
    1. Ministry of health of the Czech Republic. 2013; available at http://www.mzcr.cz/dokumenty/ockovani
    1. Fritsche PJ, Helbling A, Ballmer-Weber BK. Vaccine hypersensitivity – update and overview. Swiss Med Wkly. 2010;140:238–246. - PubMed
    1. Maglione MA, Das L, Raaen L, et al. Safety of Vaccines Used for Routine Immunization of US Children: A Systematic Review. Pediatrics. 2014;134:325–337. doi: 10.1542/peds.2014-1079. - DOI - PubMed
    1. WHO . Global manual on surveillance of adverse events following immunization. 2014.